These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26473189)

  • 1. Next-Generation Sequencing to Guide Clinical Trials.
    Siu LL; Conley BA; Boerner S; LoRusso PM
    Clin Cancer Res; 2015 Oct; 21(20):4536-44. PubMed ID: 26473189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing transformative clinical trials in the cancer genome era.
    Sleijfer S; Bogaerts J; Siu LL
    J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and current issues in single-cell sequencing of tumors.
    Sun HJ; Chen J; Ni B; Yang X; Wu YZ
    Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
    Flaherty KT; Gray R; Chen A; Li S; Patton D; Hamilton SR; Williams PM; Mitchell EP; Iafrate AJ; Sklar J; Harris LN; McShane LM; Rubinstein LV; Sims DJ; Routbort M; Coffey B; Fu T; Zwiebel JA; Little RF; Marinucci D; Catalano R; Magnan R; Kibbe W; Weil C; Tricoli JV; Alexander B; Kumar S; Schwartz GK; Meric-Bernstam F; Lih CJ; McCaskill-Stevens W; Caimi P; Takebe N; Datta V; Arteaga CL; Abrams JS; Comis R; O'Dwyer PJ; Conley BA;
    J Natl Cancer Inst; 2020 Oct; 112(10):1021-1029. PubMed ID: 31922567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome network medicine: innovation to overcome huge challenges in cancer therapy.
    Roukos DH
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(2):201-8. PubMed ID: 24318985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.
    Tran B; Brown AM; Bedard PL; Winquist E; Goss GD; Hotte SJ; Welch SA; Hirte HW; Zhang T; Stein LD; Ferretti V; Watt S; Jiao W; Ng K; Ghai S; Shaw P; Petrocelli T; Hudson TJ; Neel BG; Onetto N; Siu LL; McPherson JD; Kamel-Reid S; Dancey JE
    Int J Cancer; 2013 Apr; 132(7):1547-55. PubMed ID: 22948899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revolutionizing cancer drug development: Harnessing the potential of basket trials.
    Subbiah V; Burris HA; Kurzrock R
    Cancer; 2024 Jan; 130(2):186-200. PubMed ID: 37934000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How next-generation sequencing could change cancer care.
    O'Hanlon LH
    J Natl Cancer Inst; 2013 Jun; 105(12):836-8. PubMed ID: 23733908
    [No Abstract]   [Full Text] [Related]  

  • 16. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modernizing Eligibility Criteria for Molecularly Driven Trials.
    Kim ES; Bernstein D; Hilsenbeck SG; Chung CH; Dicker AP; Ersek JL; Stein S; Khuri FR; Burgess E; Hunt K; Ivy P; Bruinooge SS; Meropol N; Schilsky RL
    J Clin Oncol; 2015 Sep; 33(25):2815-20. PubMed ID: 26195710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
    Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
    Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of next-generation sequencing in gastrointestinal and liver tumors.
    Mikhail S; Faltas B; Salem ME; Bekaii-Saab T
    Cancer Lett; 2016 May; 374(2):187-91. PubMed ID: 26916979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.